Case Reports

Daratumumab for treatment-refractory acquired idiopathic pure red cell aplasia

Division of Hematology, Mayo Clinic, Rochester, MN
Division of Hematology and Hematopathology, Sanford Health, Sioux Falls, SD
Division of Hematology and Hematopathology, Sanford Health, Sioux Falls, SD
Division of Hematopathology, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Rochester, MN
Haematologica Early view Jun 9, 2022 https://doi.org/10.3324/haematol.2022.281398